Results 51 to 60 of about 22,536 (217)

Metaplasia of Chronic Cholecystitis (hematoxylin-eosin stain,×100).

open access: yes, 2013
Metaplasia of Chronic Cholecystitis (hematoxylin-eosin stain,×100).
Zhi-wei Quan (5655880)   +5 more
core   +1 more source

Derivation and Validation of a Predictive Model for Advanced Colorectal Neoplasia Among Average‐Risk Adults in China

open access: yesInternational Journal of Cancer, EarlyView.
Efficient pre‐colonoscopy risk stratification tools are needed, especially in China. Using multicenter colorectal cancer screening data from Shandong Province, the authors developed and validated a risk prediction model for advanced colorectal neoplasia in asymptomatic individuals using sociodemographic characteristics, lifestyle factors, and medical ...
Yan Liu   +6 more
wiley   +1 more source

Comparative Evaluation of Laparoscopic Cholecystectomy in Acute and Chronic Cholecystectomy

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2013
BACKGROUND AND OBJECTIVE: Laparoscopic cholecystectomy has been performed for the management of hepatobiliary diseases. Early laparoscopic cholecystectomy (LC) was contraindication for acute cholecystitis (AC).
AA Darzi,   +6 more
doaj  

Outcome of laparoscopic cholecystectomy in acute and chronic cholecystitis.

open access: yesمجلة كلية الطب, 2010
Background: laparoscopic cholecystectomy is standard treatment in gallbladder disease. Acute cholecystitis has been relative contraindication of laparoscopic cholecystectomy.
Omar S. Khattab
doaj   +1 more source

Endoscopic small bowel therapies for type 2 diabetes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel   +4 more
wiley   +1 more source

Mini‐cholecystectomy: a personal series in acute and chronic cholecystitis

open access: yes, 2003
BackgroundMinimally invasive techniques in the surgical treatment of gallbladder disease include laparoscopic cholecystectomy (LC) and mini‐cholecystectomy (MC).
Watanapa, P
core   +1 more source

Review of nutrition management of pediatric intestinal pseudo‐obstruction

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Chronic intestinal pseudo‐obstruction (CIPO) is a rare, heterogeneous, and debilitating disorder characterized by profound intestinal dysmotility and severe nutrition challenges. Its presentation resembles that of mechanical bowel obstruction, but CIPO occurs in the absence of luminal obstruction.
Senthilkumar Sankararaman   +5 more
wiley   +1 more source

Spectrum of Histopathological Lesions in Laparoscopic Cholecystectomy Specimens and Incidental Carcinoma Rate: Our Surgical and Clinical Experience [PDF]

open access: yesDüzce Tıp Fakültesi Dergisi, 2015
Aim: Laparoscopic cholecystectomy (LC) has become the standard treatment method of cholelithiasis. The chronic cholecystitis and cholelithiasis are the most common pathologies seen in gallbladder disease, accompanying hyperplastic and dysplastic lesions.
İlhan Bali   +3 more
doaj  

Is There a Correlation between Helicobacter Pylori and Enterohepatic Helicobacter Species and Gallstone Cholecystitis?

open access: yesMiddle East Journal of Digestive Diseases, 2018
BACKGROUND Cholecystitis is a common surgical condition. Recently, several authors have reported that DNA of bile tolerant Helicobacter spp. has been found in the human bile colonizing the biliary tract.
Seyed Masih Fatemi   +7 more
doaj   +1 more source

Salmonella Enteritidis cholecystitis with chronic granulomatous disease

open access: yes, 2018
We describe a 40-year-old woman with Salmonella cholecystitis complicating adult-onset X-linked chronic granulomatous disease (CGD) caused by a de novo mutation in the paternal-origin CYBB gene.
Takeji Umemura   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy